By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Laboratory Corporation of America Holdings (LabCorp)  

1447 York Court

Burlington  North Carolina  27215  U.S.A.
Phone: 336-584-5171 or 800-331-2843 Fax: n/a



Celera Diagnostics  Collaboration agreement to establish the clinical utility of tests based on novel diagnostic markers for Alzheimer's disease, breast cancer and prostate cancer.

Company News
New Complementary Diagnostic Test Available From LabCorp (LH) For Treatment Of Bladder Cancer 5/19/2016 10:49:46 AM
LabCorp (LH) Announces The Launch Of The Epi Procolon Test For Colorectal Cancer Screening 5/9/2016 10:53:21 AM
LabCorp (LH) Is First U.S. Laboratory Network To Offer Epigenomics AG’ Epi Pro Colon Colorectal Cancer Screening Test, Nationally Available Immediately 5/9/2016 10:33:58 AM
LabCorp (LH) To Webcast Its Annual Meeting Of Stockholders 5/6/2016 9:18:06 AM
LabCorp (LH) Announces 2016 First Quarter Results And Raises 2016 Guidance 4/25/2016 10:54:57 AM
LabCorp (LH) Hires Jonathan Zung As Group President Of Clinical Development And Commercialization Services For Covance (CVD) Drug Development 4/11/2016 8:29:59 AM
LabCorp (LH)'s Zero Coupon Convertible Subordinated Notes Due 2021 To Accrue Contingent Interest 3/11/2016 10:25:14 AM
LabCorp (LH) Is Scheduled To Present At The Barclays Capital 2016 Global Healthcare Conference 3/8/2016 10:29:12 AM
LabCorp (LH) Is Scheduled To Present At The 37th Annual Raymond James Institutional Investors Conference 3/2/2016 11:58:32 AM
LabCorp (LH) Announces 2015 Fourth Quarter And Full Year Results And Provides 2016 Guidance 2/18/2016 10:46:26 AM